AmerisourceBergen Corp. (NYSE:ABC) insider Dale Danilewitz sold 543 shares of the firm’s stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of $81.16, for a total value of $44,069.88. Following the sale, the insider now directly owns 1,085 shares of the company’s stock, valued at $88,058.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Dale Danilewitz also recently made the following trade(s):

  • On Tuesday, May 7th, Dale Danilewitz sold 5,702 shares of AmerisourceBergen stock. The stock was sold at an average price of $77.61, for a total value of $442,532.22.
  • On Tuesday, April 23rd, Dale Danilewitz sold 543 shares of AmerisourceBergen stock. The stock was sold at an average price of $71.20, for a total value of $38,661.60.
  • On Monday, April 8th, Dale Danilewitz sold 5,703 shares of AmerisourceBergen stock. The stock was sold at an average price of $77.22, for a total value of $440,385.66.
  • On Monday, March 25th, Dale Danilewitz sold 543 shares of AmerisourceBergen stock. The stock was sold at an average price of $78.77, for a total value of $42,772.11.
  • On Thursday, March 7th, Dale Danilewitz sold 5,702 shares of AmerisourceBergen stock. The stock was sold at an average price of $77.02, for a total value of $439,168.04.
  • On Monday, February 25th, Dale Danilewitz sold 543 shares of AmerisourceBergen stock. The stock was sold at an average price of $86.30, for a total value of $46,860.90.

Shares of AmerisourceBergen stock opened at $80.68 on Friday. The firm has a market capitalization of $16.96 billion, a PE ratio of 12.43, a price-to-earnings-growth ratio of 1.57 and a beta of 1.07. The company has a quick ratio of 0.56, a current ratio of 0.95 and a debt-to-equity ratio of 1.43. AmerisourceBergen Corp. has a 12 month low of $69.36 and a 12 month high of $94.88.

AmerisourceBergen (NYSE:ABC) last issued its earnings results on Thursday, May 2nd. The company reported $2.11 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.96 by $0.15. The business had revenue of $43.32 billion during the quarter, compared to analysts’ expectations of $43.44 billion. AmerisourceBergen had a return on equity of 46.24% and a net margin of 0.53%. AmerisourceBergen’s revenue was up 5.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.94 earnings per share. As a group, analysts predict that AmerisourceBergen Corp. will post 6.81 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 3rd. Stockholders of record on Monday, May 20th will be given a $0.40 dividend. The ex-dividend date is Friday, May 17th. This represents a $1.60 annualized dividend and a dividend yield of 1.98%. AmerisourceBergen’s dividend payout ratio (DPR) is presently 24.65%.

Several institutional investors have recently modified their holdings of ABC. Acima Private Wealth LLC purchased a new stake in shares of AmerisourceBergen during the fourth quarter worth $26,000. Rational Advisors LLC raised its holdings in shares of AmerisourceBergen by 1,627.3% during the first quarter. Rational Advisors LLC now owns 380 shares of the company’s stock worth $30,000 after acquiring an additional 358 shares in the last quarter. Riverview Trust Co raised its holdings in shares of AmerisourceBergen by 127.3% during the first quarter. Riverview Trust Co now owns 391 shares of the company’s stock worth $31,000 after acquiring an additional 219 shares in the last quarter. Private Capital Group LLC raised its holdings in shares of AmerisourceBergen by 201.3% during the fourth quarter. Private Capital Group LLC now owns 482 shares of the company’s stock worth $36,000 after acquiring an additional 322 shares in the last quarter. Finally, JNBA Financial Advisors purchased a new stake in shares of AmerisourceBergen during the fourth quarter worth $37,000. 65.71% of the stock is owned by institutional investors and hedge funds.

Several equities research analysts have recently weighed in on the company. ValuEngine raised AmerisourceBergen from a “strong sell” rating to a “sell” rating in a research note on Friday, May 3rd. Bank of America lowered AmerisourceBergen from a “buy” rating to an “underperform” rating and reduced their price objective for the stock from $95.00 to $76.00 in a research note on Wednesday, April 10th. Wolfe Research initiated coverage on AmerisourceBergen in a research note on Tuesday, April 2nd. They set a “market perform” rating for the company. Zacks Investment Research cut AmerisourceBergen from a “hold” rating to a “sell” rating in a research report on Monday, March 25th. Finally, Guggenheim initiated coverage on AmerisourceBergen in a research report on Thursday, April 11th. They issued a “buy” rating for the company. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $86.38.

ILLEGAL ACTIVITY WARNING: This story was first posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://www.watchlistnews.com/amerisourcebergen-corp-abc-insider-dale-danilewitz-sells-543-shares/3022773.html.

About AmerisourceBergen

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Further Reading: Hedge Funds – How They Work For Investors

Insider Buying and Selling by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.